SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-118726
Filing Date
2011-04-29
Accepted
2011-04-29 16:42:56
Documents
3
Period of Report
2011-04-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 20820
2 FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT dex101.htm EX-10.1 14463
3 1ST AMEND. TO LOAN & SEC AGMT, BETWEEN LIGAND AND OXFORD FINANCE dex102.htm EX-10.2 22733
  Complete submission text file 0001193125-11-118726.txt   59303
Mailing Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037
Business Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 11795495
SIC: 2834 Pharmaceutical Preparations